Home  /  News  /  McAndrews News

McAndrews Sponsors Annual Biotech Event on Developments in Stem Cell Research and Regenerative Medicine

Date: April 9, 2015 || McAndrews News

McAndrews is pleased to announce its sponsorship of the 10th Annual Wisconsin Stem Cell Symposium, hosted by the Stem Cell & Regenerative Medicine Center, at the University of Wisconsin-Madison and the BioPharmaceutical Technology Center (BTC) Institute.

The event will be held on April 22, 2015, at the BTC Institute in Madison, Wisconsin, and will bring together leading researchers who are working in the areas of limb development and regeneration, and stem cells and tissue engineering. Presenters include a long list of distinguished business representatives, professors and other thought leaders from major companies, colleges and universities around the world.

McAndrews, Held & Malloy, one of the nation’s most highly regarded intellectual property and complex technology law firms, routinely handles cases that involve innovation and cutting-edge technologies in specialized industries, including various forms of stem cells, their processing and therapeutic usages. Representing leading biotechnology and pharmaceutical companies, such as Promega and Mesoblast, McAndrews stays at the forefront of industry developments that can impact its clients. 

To many of the world’s leading companies in the pharmaceutical and biotechnology industries, McAndrews provides a complete and comprehensive range of IP services, including patent litigation, patent prosecution and portfolio management, post-grant proceedings (e.g., inter partes review), interferences, freedom-to-operate and patent validity opinions, due diligence, licensing, and other advanced IP transactions. Many of the firm’s attorneys and patent agents hold Ph.D.’s in fields such as chemistry, biochemistry, cell and molecular biology, biomaterials and cancer biology.